New Breakthrough in Aggressive Breast Cancer

There’s new hope for patients with aggressive triple-negative breast cancer. Recent research shows that combining chemotherapy with the immunotherapy drug pembrolizumab before and after surgery can significantly improve survival rates. This breakthrough treatment, highlighted in the KEYNOTE-522 tria

New Breakthrough in Aggressive Breast Cancer
Template for Youtube (16)

Read more